CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
Project Khanyabehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03529409
NCT03529409N/ACompleted

Hybrid Effectiveness-Implementation Trial for ART Adherence and Substance Use in HIV Care in South Africa

University of Maryland, College Park·interventional·Posted May 18, 2018·Updated May 18, 2022

In Brief

A clinical study evaluating Project Khanya for Human Immunodeficiency Virus and 2 related conditions. Completed, enrolled 66 participants across 2 sites in 2 countries.

Detailed Summary

The purpose of this study is to test the effectiveness and implementation of a brief, integrated behavioral intervention for HIV medication adherence and substance use in the HIV care setting in South Africa. The intervention is specifically designed to be implemented by non-specialist counselors using a task sharing model in local HIV clinics. The behavioral intervention will be compared to usual care, enhanced with referral to a local outpatient substance use treatment program (Enhanced Standard of Care - ESOC) on study endpoints (as described in study endpoint section below).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Africa, United States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 18, 2018
Enrollment StartJul 30, 2018
Primary CompletionFeb 12, 2020
Study CompletionApr 7, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.1 years ago

Interventions

Project Khanyabehavioral

This treatment involves integrating a behavioral intervention for substance use with a behavioral intervention for adherence.